Thanks for your interest in Transpharmation Ltd. We'd like to keep you updated on what's new and relevant. Please sign up to receive our newsletters, we won't bombard you or share your details with any other party and you can unsubscribe at any time.
New service - PBMC's
We are pleased to offer this new translational assay of inflammation
PBMCs: a robust and translational model of inflammation suitable for high-throughput screening, (Peripheral Blood Mononuclear Cells).
The immune system, and in particular inflammatory signalling, has emerged as a promising therapeutic target for a variety of diseases, including neurological and psychiatric disorders. Following the long-term success of our molecular biomarker discovery platform and preclinical models of inflammation, we are now offering similar endpoints in the translationally-relevant human PBMC assay.
Ex vivo stimulation of PBMCs isolated from human blood constitutes a useful molecular tool for efficiently screening novel compounds targeting inflammatory processes. This effective drug discovery assay can be tailored to meet your needs and enhance the translation of preclinical findings to clinical efficacy; complementing our extensive range of preclinical in vivo and ex vivo capabilities. We hope the early success of this clinically-relevant model will enable further expansion to a wide range of disease areas enabling high-throughput screening of novel anti-inflammatory therapies.
Transpharmation to attend Neuroimmunology Drug Development Summit in Boston
This industry-focused networking forum - April 17th & 18th - is aimed at learning and sharing insight on how to successfully target chronic neuroinflammation as a universal therapeutic for various neurological diseases - View summit. Transpharmation are looking forward to presenting scientific posters at this event. If you are not attending, please apply to our website to download a copies at the end of April.
Stay up to date with our latest services, posters and news by visiting our website regularly. Find out which conferences we'll be attending and presenting at during 2020 too. Encourage your colleagues to sign up for their own copy of this newsletter - there's a sign up button on our homepage.
We’re always keen to hear from you
Please feel free to get in touch with me if you have a piece of work that you'd like to discuss or if you'd like to arrange a visit. I look forward to hearing from you.
You are receiving this newsletter because you have expressed an interest in Transpharmation in the past. If you no longer wish to receive communications such as this from us please unsubscribe here Unsubscribe Thank you.